SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001847903-24-000095
Filing Date
2024-06-25
Accepted
2024-06-25 16:14:31
Documents
14
Period of Report
2024-06-25
Items
Item 5.07: Submission of Matters to a Vote of Security Holders

Document Format Files

Seq Description Document Type Size
1 8-K cnta-20240625.htm   iXBRL 8-K 51226
  Complete submission text file 0001847903-24-000095.txt   233353

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT cnta-20240625.xsd EX-101.SCH 2737
3 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT cnta-20240625_def.xml EX-101.DEF 16868
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT cnta-20240625_lab.xml EX-101.LAB 30840
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT cnta-20240625_pre.xml EX-101.PRE 18275
17 EXTRACTED XBRL INSTANCE DOCUMENT cnta-20240625_htm.xml XML 4497
Mailing Address 3RD FLOOR 1 ASHLEY ROAD ALTRINCHAM, CHESHIRE X0 WA14 2DT
Business Address 3RD FLOOR 1 ASHLEY ROAD ALTRINCHAM, CHESHIRE X0 WA14 2DT 44 7391 789784
Centessa Pharmaceuticals plc (Filer) CIK: 0001847903 (see all company filings)

IRS No.: 000000000 | State of Incorp.: X0 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40445 | Film No.: 241069112
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)